{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:25:40Z","timestamp":1789655140664,"version":"4.0.1"},"reference-count":286,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>The thionamide antithyroid drugs were discovered in large part following serendipitous observations by a number of investigators in the 1940s who found that sulfhydryl-containing compounds were goitrogenic in animals. This prompted Prof. Edwin B Astwood to pioneer the use of these compounds to treat hyperthyroidism in the early 1940s and to develop the more potent and less toxic drugs that are used today. Despite their simple molecular structure and ease of use, many uncertainties remain, including their mechanism(s) of action, clinical role, optimal use in pregnancy and the prediction and prevention of rare but potentially life-threatening adverse reactions. In this review, we summarize the history of the development of these drugs and outline their current role in the clinical management of patients with hyperthyroidism.<\/jats:p>","DOI":"10.1530\/eje-18-0678","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T12:54:52Z","timestamp":1536065692000},"page":"R261-R274","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":106,"title":["Antithyroid drug therapy: 70 years later"],"prefix":"10.1093","volume":"179","author":[{"given":"Henry B","family":"Burch","sequence":"first","affiliation":[{"name":"1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Cooper","sequence":"additional","affiliation":[{"name":"2Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"ref2291","year":"2018","journal-title":"Life-Threatening ThyrotoxicosisL"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/thy.2005.15.787","article-title":"Biochemical mechanisms of thyroid hormone deiodination","volume":"15","year":"2005","journal-title":"Thyroid"},{"key":"ref551","first-page":"1516","article-title":"A prospective randomized trial of antithyroid drug dose in Graves\u2019 disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment","volume":"76","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2341","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","article-title":"2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).","volume":"63","year":"2016","journal-title":"Endocrine Journal"},{"key":"ref2541","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2013-2569","article-title":"Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2761","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.1780270216","article-title":"The antithyroid arthritis syndrome reviewed","volume":"27","year":"1984","journal-title":"Arthritis and Rheumatism"},{"key":"ref2011","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves\u2019 disease undergoing remission after antithyroid drug treatment","volume":"7","year":"1997","journal-title":"Thyroid"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2265.1988.tb01217.x","article-title":"Comparison of methimazole, methimazole and sodium Ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves\u2019 disease","volume":"28","year":"1988","journal-title":"Clinical Endocrinology"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1021\/ar4001229","article-title":"Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action","volume":"46","year":"2013","journal-title":"Accounts of Chemical Research"},{"key":"ref2561","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/eje.1.01904","article-title":"Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine","volume":"152","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref81","first-page":"1229","article-title":"Thiouracil treatment in hyperthyroidism","volume":"4","year":"1944","journal-title":"Journal of Clinical Endocrinology"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02295","article-title":"Remission of Graves\u2019 disease during anti-thyroid drug therapy. Time to reconsider the mechanism?","volume":"155","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2012.04365.x","article-title":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","volume":"77","year":"2012","journal-title":"Clinical Endocrinology"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/cen.12478","article-title":"Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves\u2019 disease: a retrospective observational study","volume":"81","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"ref2741","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","article-title":"Methimazole-induced hepatotoxicity","volume":"8","year":"2002","journal-title":"Endocrine Practice"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1984.03340370075036","article-title":"Landmark article May 8, 1943: treatment of hyperthyroidism with thiourea and thiouracil","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1021\/ar4001229","article-title":"Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action","volume":"46","year":"2013","journal-title":"Accounts of Chemical Research"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves\u2019 disease","volume":"316","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejim.2012.07.007","article-title":"Immune manipulation for Graves\u2019 disease: re-exploring an unfulfilled promise with modern translational research","volume":"23","year":"2012","journal-title":"European Journal of Internal Medicine"},{"key":"ref2551","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/thy.2011.0039","article-title":"Sustained control of Graves\u2019 hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves\u2019 orbitopathy","volume":"21","year":"2011","journal-title":"Thyroid"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/105072501750302886","article-title":"Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves\u2019 disease","volume":"11","year":"2001","journal-title":"Thyroid"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/150233b0","article-title":"Thioureas as goitrogenic substances","volume":"150","year":"1942","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/endo-32-2-185","article-title":"Effect of sulfonamides and thioureas on the thyroid gland and basal metabolism.","volume":"32","year":"1943","journal-title":"Endocrinology"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease","volume":"343","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"ref2321","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-121-8-199410150-00001","article-title":"Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves disease","volume":"121","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"ref2831","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","article-title":"Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves\u2019 disease","volume":"60","year":"2004","journal-title":"Clinical Endocrinology"},{"key":"ref1411","article-title":"Antithyroid arthritis syndrome","volume":"2017","year":"2017","journal-title":"BMJ Case Reports"},{"key":"ref2601","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","year":"1990","journal-title":"Archives of Internal Medicine"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08916939809003862","article-title":"Evidence for carbimazole as an antioxidant?","volume":"27","year":"1998","journal-title":"Autoimmunity"},{"key":"ref981","first-page":"2410","article-title":"Medical therapy of Graves\u2019 disease: does thyroxine prevent recurrence of hyperthyroidism?","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2641","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/thy.2008.0364","article-title":"Methimazole-induced agranulocytosis in patients with Graves\u2019 disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily","volume":"19","year":"2009","journal-title":"Thyroid"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1530\/acta.0.0930032","article-title":"Effects of propylthiouracil and methylmercaptoimidazole on thyroglobulin synthesis","volume":"93","year":"1980","journal-title":"Acta Endocrinology"},{"key":"ref2331","first-page":"485","article-title":"Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial","volume":"149","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis. Thyroid storm","volume":"22","year":"1993","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1210\/jcem.85.9.6810","article-title":"Thyroid function and intellectual development of infants nursed by mothers taking methimazole","volume":"85","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/ehm.11.12","article-title":"Clinical presentation and management of drug-induced agranulocytosis","volume":"4","year":"2011","journal-title":"Expert Review of Hematology"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/thy.2016.0652","article-title":"Long-term antithyroid drug treatment: a systematic review and meta-analysis","volume":"27","year":"2017","journal-title":"Thyroid"},{"key":"ref1461","first-page":"46","article-title":"Toxic effects of the bitter-tasting phenylthiocarbamide","volume":"33","year":"1942","journal-title":"Archives of Pathology"},{"key":"ref2411","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJM199601253340403","article-title":"Lack of effect of thyroxine in patients with Graves\u2019 hyperthyroidism who are treated with an antithyroid drug","volume":"334","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"ref1361","first-page":"64","article-title":"Thyrotoxicosis and collagen-like disease in three sisters of American Indian extraction","volume":"76","year":"1970","journal-title":"Jurnalul Pediatrului"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/thy.2005.15.787","article-title":"Biochemical mechanisms of thyroid hormone deiodination","volume":"15","year":"2005","journal-title":"Thyroid"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-62-1-217","article-title":"Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests","volume":"62","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2861","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13317-012-0028-1","article-title":"Blocking type TSH receptor antibodies","volume":"4","year":"2013","journal-title":"Auto Immun Highlights"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2013-2569","article-title":"Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2061","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-8-9-717","article-title":"The collection of radioactive iodine by the human fetal thyroid","volume":"8","year":"1948","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1210\/endo-32-2-210","article-title":"Action of certain sulfonamides and of thiourea upon the function of the thyroid gland of the rat 1","volume":"32","year":"1943","journal-title":"Endocrinology"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03343979","article-title":"Does smoking increase relapse rates in Graves\u2019 disease?","volume":"25","year":"2002","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9120(99)00024-7","article-title":"Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients","volume":"32","year":"1999","journal-title":"Clinical Biochemistry"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2015-4274","article-title":"Antithyroid drug side effects in the population and in pregnancy","volume":"101","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2261","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"ref2591","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2012.04365.x","article-title":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","volume":"77","year":"2012","journal-title":"Clinical Endocrinology"},{"key":"ref2371","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2265.1988.tb01217.x","article-title":"Comparison of methimazole, methimazole and sodium Ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves\u2019 disease","volume":"28","year":"1988","journal-title":"Clinical Endocrinology"},{"key":"ref2611","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/qjmed\/92.8.455","article-title":"Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","year":"1999","journal-title":"Quarterly Journal of Medicine"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1124\/jpet.107.132407","article-title":"Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha","volume":"324","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref2571","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves\u2019 disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-2007-978808","article-title":"Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment","volume":"31","year":"1999","journal-title":"Hormone and Metabolic Research"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1172\/JCI107744","article-title":"Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents","volume":"54","year":"1974","journal-title":"Journal of Clinical Investigation"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/exer.1997.0353","article-title":"Superoxide radical production stimulates retroocular fibroblast proliferation in Graves\u2019 ophthalmopathy","volume":"65","year":"1997","journal-title":"Experimental Eye Research"},{"key":"ref2851","article-title":"Antithyroid arthritis syndrome","volume":"2017","year":"2017","journal-title":"BMJ Case Reports"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.94.2448.518","article-title":"The effect of sulfanilylguanidine on the thyroid of the rat","volume":"94","year":"1941","journal-title":"Science"},{"key":"ref2661","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.1986.tb04130.x","article-title":"Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells","volume":"64","year":"1986","journal-title":"British Journal of Haematology"},{"key":"ref2041","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1210\/jc.2008-0966","article-title":"The effect of pregnancy on subsequent relapse from Graves\u2019 disease after a successful course of antithyroid drug therapy","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref731","first-page":"315","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.","volume-title":"Thyroid","volume":"2017","year":"2017"},{"key":"ref2081","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2821","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2002-021383","article-title":"Frequency of antineutrophil cytoplasmic antibody in Graves\u2019 disease patients treated with methimazole","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref111","first-page":"873","article-title":"Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline); report of 120 cases","volume":"1","year":"1953","journal-title":"Lancet"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2006.04.013","article-title":"Determination of oxidative stress in thyroid tissue and plasma of patients with Graves\u2019 disease","volume":"17","year":"2006","journal-title":"European Journal of Internal Medicine"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves\u2019 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","year":"2008","journal-title":"European Journal of Endocrinology"},{"key":"ref871","first-page":"3016","article-title":"The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves\u2019 disease","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2511","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02169","article-title":"What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves\u2019 disease","volume":"154","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/endo-98-4-1031","article-title":"The mechanism of action of the thioureylene antithyroid drugs","volume":"98","year":"1976","journal-title":"Endocrinology"},{"key":"ref1691","year":"1967","journal-title":"Thyrotoxicosis"},{"key":"ref1501","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3565(25)09476-5","article-title":"The chemical nature of compounds which inhibit the function of the thyroid gland","volume":"78","year":"1943","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole and carbimazole","volume":"45","year":"1977","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08916939809003862","article-title":"Evidence for carbimazole as an antioxidant?","volume":"27","year":"1998","journal-title":"Autoimmunity"},{"key":"ref2361","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jcem-45-4-623","article-title":"Combination drug therapy for treatment of hyperthyroid Grave\u2019s disease","volume":"45","year":"1977","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"97","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2671","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2002.01720.x","article-title":"Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity","volume":"127","year":"2002","journal-title":"Clinical and Experimental Immunology"},{"key":"ref2491","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/cen.12478","article-title":"Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves\u2019 disease: a retrospective observational study","volume":"81","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"ref1821","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1530\/acta.0.1120210","article-title":"Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils","volume":"112","year":"1986","journal-title":"Acta Endocrinology"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejim.2012.07.007","article-title":"Immune manipulation for Graves\u2019 disease: re-exploring an unfulfilled promise with modern translational research","volume":"23","year":"2012","journal-title":"European Journal of Internal Medicine"},{"key":"ref461","first-page":"1343","article-title":"American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume-title":"Thyroid","volume":"2016","year":"2016"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves\u2019 disease","volume":"316","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jcem-26-8-803","article-title":"Long-term outcome of hyperthyroidism treated with antithyroid drugs","volume":"26","year":"1966","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1530\/acta.0.1120210","article-title":"Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils","volume":"112","year":"1986","journal-title":"Acta Endocrinology"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/acta.0.0930315","article-title":"Effects of propylthiouracil and relatively small doses of iodide on early phase treatment of hyperthyroidism","volume":"93","year":"1980","journal-title":"Acta Endocrinology"},{"key":"ref2781","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2015-4274","article-title":"Antithyroid drug side effects in the population and in pregnancy","volume":"101","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"84","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"ref2231","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves\u2019 hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem-57-1-129","article-title":"Intrathyroidal concentrations of methimazole in patients with Graves\u2019 disease","volume":"57","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1521","first-page":"1229","article-title":"Thiouracil treatment in hyperthyroidism","volume":"4","year":"1944","journal-title":"Journal of Clinical Endocrinology"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/endo-98-4-1031","article-title":"The mechanism of action of the thioureylene antithyroid drugs","volume":"98","year":"1976","journal-title":"Endocrinology"},{"key":"ref2121","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/tera.1072","article-title":"Adverse effects of prenatal methimazole exposure","volume":"64","year":"2001","journal-title":"Teratology"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02295","article-title":"Remission of Graves\u2019 disease during anti-thyroid drug therapy. Time to reconsider the mechanism?","volume":"155","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.2010.0181","article-title":"Outcome of very long-term treatment with antithyroid drugs in Graves\u2019 hyperthyroidism associated with Graves\u2019 orbitopathy","volume":"21","year":"2011","journal-title":"Thyroid"},{"key":"ref2421","first-page":"2410","article-title":"Medical therapy of Graves\u2019 disease: does thyroxine prevent recurrence of hyperthyroidism?","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2391","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2009.03745.x","article-title":"Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves\u2019 disease","volume":"72","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"ref2431","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/eje.0.1360081","article-title":"Suppression of serum thyrotropin with thyroxine in patients with Graves\u2019 disease: effects on recurrence of hyperthyroidism and thyroid volume","volume":"136","year":"1997","journal-title":"European Journal of Endocrinology"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bmj.288.6416.518","article-title":"Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression","volume":"288","year":"1984","journal-title":"BMJ"},{"key":"ref2151","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States","volume":"23","year":"2013","journal-title":"Thyroid"},{"key":"ref2401","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199104043241403","article-title":"Administration of thyroxine in treated Graves\u2019 disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism","volume":"324","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem?","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2004.02029.x","article-title":"Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves\u2019 disease","volume":"60","year":"2004","journal-title":"Clinical Endocrinology"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1530\/acta.0.0790248","article-title":"Binding of the 35-s of 35-s-propylthiouracil by follicular thyroglobulin in vivo and in vitro","volume":"79","year":"1975","journal-title":"Acta Endocrinology"},{"key":"ref1991","first-page":"1516","article-title":"A prospective randomized trial of antithyroid drug dose in Graves\u2019 disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment","volume":"76","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1511","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1984.03340370075036","article-title":"Landmark article May 8, 1943: treatment of hyperthyroidism with thiourea and thiouracil","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1210\/endo-32-2-210","article-title":"Action of certain sulfonamides and of thiourea upon the function of the thyroid gland of the rat 1","volume":"32","year":"1943","journal-title":"Endocrinology"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJM199601253340403","article-title":"Lack of effect of thyroxine in patients with Graves\u2019 hyperthyroidism who are treated with an antithyroid drug","volume":"334","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9120(99)00024-7","article-title":"Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients","volume":"32","year":"1999","journal-title":"Clinical Biochemistry"},{"key":"ref2691","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(79)90692-0","article-title":"Accumulation of 2-[14C]propylthiouracil in human polymorphonuclear leukocytes","volume":"28","year":"1979","journal-title":"Biochemistry and Pharmacology"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2016.0222","article-title":"Antithyroid drugs-the most common treatment for Graves\u2019 disease in the United States: a nationwide population-based study","volume":"26","year":"2016","journal-title":"Thyroid"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13317-012-0028-1","article-title":"Blocking type TSH receptor antibodies","volume":"4","year":"2013","journal-title":"Auto Immun Highlights"},{"key":"ref1031","first-page":"475","article-title":"Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves\u2019 hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study","volume":"144","year":"2001","journal-title":"European Journal of Endocrinology"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/endo-44-6-588","article-title":"1-Methyl-2-mercaptoimidazole; an antithyroid compound highly active in man","volume":"44","year":"1949","journal-title":"Endocrinology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/endo-44-6-588","article-title":"1-Methyl-2-mercaptoimidazole; an antithyroid compound highly active in man","volume":"44","year":"1949","journal-title":"Endocrinology"},{"key":"ref2701","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1038\/ncomms8633","article-title":"Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study","volume":"6","year":"2015","journal-title":"Nature Communications"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000367990","article-title":"Patient knowledge of antithyroid drug-induced agranulocytosis","volume":"3","year":"2014","journal-title":"European Thyroid Journal"},{"key":"ref2021","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03343979","article-title":"Does smoking increase relapse rates in Graves\u2019 disease?","volume":"25","year":"2002","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref2201","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1210\/jcem.85.9.6810","article-title":"Thyroid function and intellectual development of infants nursed by mothers taking methimazole","volume":"85","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/thy.2011.0039","article-title":"Sustained control of Graves\u2019 hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves\u2019 orbitopathy","volume":"21","year":"2011","journal-title":"Thyroid"},{"key":"ref2101","first-page":"3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves\u2019 hyperthyroidism","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","article-title":"Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinology"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/thy.2000.10.527","article-title":"Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves\u2019 disease","volume":"10","year":"2000","journal-title":"Thyroid"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM197702032960509","article-title":"Propranolol does not prevent thyroid storm","volume":"296","year":"1977","journal-title":"New England Journal of Medicine"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0005-2744(80)90074-1","article-title":"Mechanism of inhibition of iodothyronine-5\u2032-deiodinase by thioureylenes and sulfite","volume":"611","year":"1980","journal-title":"Biochimica et Biophysica Acta"},{"key":"ref2171","first-page":"315","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum.","volume-title":"Thyroid","volume":"2017","year":"2017"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2265.2000.01078.x","article-title":"Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil","volume":"53","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-121-8-199410150-00001","article-title":"Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves disease","volume":"121","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"ref2481","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves\u2019 disease","volume":"343","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1381612013397898","article-title":"The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: a review","volume":"7","year":"2001","journal-title":"Current Pharmaceutical Design"},{"key":"ref2811","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem?","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref2841","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.1780270216","article-title":"The antithyroid arthritis syndrome reviewed","volume":"27","year":"1984","journal-title":"Arthritis and Rheumatism"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jcem-11-10-1045","article-title":"The use of antithyroid drugs during pregnancy","volume":"11","year":"1951","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","article-title":"Carbimazole embryopathy: an emerging phenotype","volume":"132a","year":"2005","journal-title":"American Journal of Medical Genetics: Part A"},{"key":"ref2141","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2351","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1172\/JCI107744","article-title":"Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents","volume":"54","year":"1974","journal-title":"Journal of Clinical Investigation"},{"key":"ref2451","first-page":"814","article-title":"Effect of methimazole, with or without L-thyroxine, on remission rates in Graves\u2019 disease","volume":"83","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2006.04.013","article-title":"Determination of oxidative stress in thyroid tissue and plasma of patients with Graves\u2019 disease","volume":"17","year":"2006","journal-title":"European Journal of Internal Medicine"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/105072501750302886","article-title":"Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves\u2019 disease","volume":"11","year":"2001","journal-title":"Thyroid"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.2003.01850.x","article-title":"Peripheral parameters of oxidative stress in Graves\u2019 disease: the effects of methimazole and 131 iodine treatments","volume":"59","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02169","article-title":"What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves\u2019 disease","volume":"154","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"ref1471","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/endo-32-2-185","article-title":"Effect of sulfonamides and thioureas on the thyroid gland and basal metabolism.","volume":"32","year":"1943","journal-title":"Endocrinology"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1124\/jpet.107.132407","article-title":"Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha","volume":"324","year":"2008","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves\u2019 disease undergoing remission after antithyroid drug treatment","volume":"7","year":"1997","journal-title":"Thyroid"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves\u2019 disease: an evidence-based approach to therapeutic controversies","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2381","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/acta.0.0930315","article-title":"Effects of propylthiouracil and relatively small doses of iodide on early phase treatment of hyperthyroidism","volume":"93","year":"1980","journal-title":"Acta Endocrinology"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s40618-016-0484-y","article-title":"Relation between therapy options for Graves\u2019 disease and the course of Graves\u2019 ophthalmopathy: a systematic review and meta-analysis","volume":"39","year":"2016","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/endo-103-3-871","article-title":"The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings","volume":"103","year":"1978","journal-title":"Endocrinology"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/thy.2008.0364","article-title":"Methimazole-induced agranulocytosis in patients with Graves\u2019 disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily","volume":"19","year":"2009","journal-title":"Thyroid"},{"key":"ref2241","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s40618-016-0484-y","article-title":"Relation between therapy options for Graves\u2019 disease and the course of Graves\u2019 ophthalmopathy: a systematic review and meta-analysis","volume":"39","year":"2016","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/thy.2013.0476","article-title":"Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment","volume":"24","year":"2014","journal-title":"Thyroid"},{"key":"ref2111","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1994.4.129","article-title":"Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis","volume":"4","year":"1994","journal-title":"Thyroid"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"84","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"ref2791","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","article-title":"Clinical associations between thyroid and liver diseases","volume":"10","year":"1995","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"ref2271","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.2010.0181","article-title":"Outcome of very long-term treatment with antithyroid drugs in Graves\u2019 hyperthyroidism associated with Graves\u2019 orbitopathy","volume":"21","year":"2011","journal-title":"Thyroid"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1998.00466.x","article-title":"TSH suppression combined with carbimazole for Graves\u2019 disease: effect on remission and relapse rates","volume":"48","year":"1998","journal-title":"Clinical Endocrinology"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/thy.2014.0350","article-title":"Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1210\/jc.2008-0966","article-title":"The effect of pregnancy on subsequent relapse from Graves\u2019 disease after a successful course of antithyroid drug therapy","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/endo-110-1-190","article-title":"Preferential inhibition of thyroxine and 3,5,3\u2032-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin","volume":"110","year":"1982","journal-title":"Endocrinology"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/thy.2014.0084","article-title":"Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg\/day and methimazole 30 mg\/day as initial therapy for Graves\u2019 disease patients with moderate to severe hyperthyroidism","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves\u2019 disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-48-4-572","article-title":"Changes in thyroid-stimulating immunoglobulins during antithyroid therapy","volume":"48","year":"1979","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2251","first-page":"CD010094","article-title":"Radioiodine therapy versus antithyroid medications for Graves\u2019 disease","volume":"2","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref2311","first-page":"3016","article-title":"The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves\u2019 disease","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2461","first-page":"117","article-title":"Medical therapy of Graves\u2019 disease: effect on remission rates of methimazole alone and in combination with triiodothyronine","volume":"142","year":"2000","journal-title":"European Journal of Endocrinology"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref2581","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2631","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/thy.2013.0476","article-title":"Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment","volume":"24","year":"2014","journal-title":"Thyroid"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/thy.2014.0150","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"24","year":"2014","journal-title":"Thyroid"},{"key":"ref01","first-page":"195","article-title":"Chemotherapy of hyperthyroidism","volume":"40","year":"1945","journal-title":"Harvey Lecture"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","article-title":"Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring","volume":"150","year":"1990","journal-title":"Archives of Internal Medicine"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.1986.tb04130.x","article-title":"Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells","volume":"64","year":"1986","journal-title":"British Journal of Haematology"},{"key":"ref1291","first-page":"w14243","article-title":"Rapid preoperative blockage of thyroid hormone production\/secretion in patients with Graves\u2019 disease","volume":"146","year":"2016","journal-title":"Swiss Medical Weekly"},{"key":"ref1571","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jcem-11-10-1045","article-title":"The use of antithyroid drugs during pregnancy","volume":"11","year":"1951","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2721","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/ehm.11.12","article-title":"Clinical presentation and management of drug-induced agranulocytosis","volume":"4","year":"2011","journal-title":"Expert Review of Hematology"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jcem-26-8-803","article-title":"Long-term outcome of hyperthyroidism treated with antithyroid drugs","volume":"26","year":"1966","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/eje.1.01904","article-title":"Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine","volume":"152","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy","volume":"364","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"ref1441","first-page":"195","article-title":"Chemotherapy of hyperthyroidism","volume":"40","year":"1945","journal-title":"Harvey Lecture"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jcem-5-10-424","article-title":"Thiouracil derivatives of greater activity for the treatment of hyperthyroidism","volume":"5","year":"1945","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2009.03745.x","article-title":"Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves\u2019 disease","volume":"72","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"ref2191","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2265.2000.01078.x","article-title":"Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil","volume":"53","year":"2000","journal-title":"Clinical Endocrinology"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jcem-45-4-623","article-title":"Combination drug therapy for treatment of hyperthyroid Grave\u2019s disease","volume":"45","year":"1977","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2871","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2010-1935","article-title":"A new small-molecule antagonist inhibits Graves\u2019 disease antibody activation of the TSH receptor","volume":"96","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/tera.1072","article-title":"Adverse effects of prenatal methimazole exposure","volume":"64","year":"2001","journal-title":"Teratology"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/endo-103-3-871","article-title":"The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings","volume":"103","year":"1978","journal-title":"Endocrinology"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"97","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2681","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","year":"2015","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"key":"ref2771","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/thy.2014.0350","article-title":"Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref2301","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM197702032960509","article-title":"Propranolol does not prevent thyroid storm","volume":"296","year":"1977","journal-title":"New England Journal of Medicine"},{"key":"ref891","first-page":"485","article-title":"Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial","volume":"149","year":"2003","journal-title":"European Journal of Endocrinology"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/jcem-57-1-129","article-title":"Intrathyroidal concentrations of methimazole in patients with Graves\u2019 disease","volume":"57","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.1953.03690030001001","article-title":"Prognosis of hyperthyroidism treated by antithyroid drugs","volume":"152","year":"1953","journal-title":"JAMA"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/bmj.288.6416.518","article-title":"Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression","volume":"288","year":"1984","journal-title":"BMJ"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0005-2744(80)90074-1","article-title":"Mechanism of inhibition of iodothyronine-5\u2032-deiodinase by thioureylenes and sulfite","volume":"611","year":"1980","journal-title":"Biochimica et Biophysica Acta"},{"key":"ref2211","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy","volume":"338","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy","volume":"338","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"ref641","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A systematic review of drug therapy for Graves\u2019 hyperthyroidism","volume":"153","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-2007-978808","article-title":"Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment","volume":"31","year":"1999","journal-title":"Hormone and Metabolic Research"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2002-021383","article-title":"Frequency of antineutrophil cytoplasmic antibody in Graves\u2019 disease patients treated with methimazole","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref811","first-page":"CD010094","article-title":"Radioiodine therapy versus antithyroid medications for Graves\u2019 disease","volume":"2","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/150233b0","article-title":"Thioureas as goitrogenic substances","volume":"150","year":"1942","journal-title":"Nature"},{"key":"ref2711","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","article-title":"Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinology"},{"key":"ref2521","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2016.0222","article-title":"Antithyroid drugs-the most common treatment for Graves\u2019 disease in the United States: a nationwide population-based study","volume":"26","year":"2016","journal-title":"Thyroid"},{"key":"ref661","first-page":"3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves\u2019 hyperthyroidism","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.K05-121","article-title":"TSH receptor antibody measurements and prediction of remission in Graves\u2019 disease patients treated with minimum maintenance doses of antithyroid drugs","volume":"53","year":"2006","journal-title":"Endocrine Journal"},{"key":"ref521","article-title":"Life-threatening thyrotoxicosis","volume-title":"Endocrine and Metabolic Medical Emergencies: A Clinician\u2019s Guide","year":"2018"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.1953.03690030001001","article-title":"Prognosis of hyperthyroidism treated by antithyroid drugs","volume":"152","year":"1953","journal-title":"JAMA"},{"key":"ref2071","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole and carbimazole","volume":"45","year":"1977","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.94.2448.518","article-title":"The effect of sulfanilylguanidine on the thyroid of the rat","volume":"94","year":"1941","journal-title":"Science"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1440-1746.1995.tb01106.x","article-title":"Clinical associations between thyroid and liver diseases","volume":"10","year":"1995","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/thy.2000.10.527","article-title":"Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves\u2019 disease","volume":"10","year":"2000","journal-title":"Thyroid"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves\u2019 orbitopathy","volume":"364","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"ref2621","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000367990","article-title":"Patient knowledge of antithyroid drug-induced agranulocytosis","volume":"3","year":"2014","journal-title":"European Thyroid Journal"},{"key":"ref1011","first-page":"814","article-title":"Effect of methimazole, with or without L-thyroxine, on remission rates in Graves\u2019 disease","volume":"83","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/mol.60.5.972","article-title":"Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-gamma signaling and H(2)O(2) Scavenging","volume":"60","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"ref2751","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1021","first-page":"117","article-title":"Medical therapy of Graves\u2019 disease: effect on remission rates of methimazole alone and in combination with triiodothyronine","volume":"142","year":"2000","journal-title":"European Journal of Endocrinology"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199104043241403","article-title":"Administration of thyroxine in treated Graves\u2019 disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism","volume":"324","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"ref1891","first-page":"505","article-title":"Comparative bioavailability of carbimazole and methimazole","volume":"21","year":"1983","journal-title":"International Journal of Clinical Pharmacology, Therapy and Toxicology"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"ref2281","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"ref2441","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1998.00466.x","article-title":"TSH suppression combined with carbimazole for Graves\u2019 disease: effect on remission and relapse rates","volume":"48","year":"1998","journal-title":"Clinical Endocrinology"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2002.01720.x","article-title":"Drug-induced neutropenia associated with anti-neutrophil cytoplasmic antibodies (ANCA): possible involvement of complement in granulocyte cytotoxicity","volume":"127","year":"2002","journal-title":"Clinical and Experimental Immunology"},{"key":"ref251","year":"1967","journal-title":"Thyrotoxicosis"},{"key":"ref2221","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The Thyroid Study Group","volume":"326","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-8-9-717","article-title":"The collection of radioactive iodine by the human fetal thyroid","volume":"8","year":"1948","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves\u2019 hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref21","first-page":"46","article-title":"Toxic effects of the bitter-tasting phenylthiocarbamide","volume":"33","year":"1942","journal-title":"Archives of Pathology"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/endo-110-1-190","article-title":"Preferential inhibition of thyroxine and 3,5,3\u2032-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin","volume":"110","year":"1982","journal-title":"Endocrinology"},{"key":"ref2651","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1537-2995.1983.23283172851.x","article-title":"An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome","volume":"23","year":"1983","journal-title":"Transfusion"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1530\/acta.0.0930032","article-title":"Effects of propylthiouracil and methylmercaptoimidazole on thyroglobulin synthesis","volume":"93","year":"1980","journal-title":"Acta Endocrinology"},{"key":"ref1941","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/mol.60.5.972","article-title":"Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-gamma signaling and H(2)O(2) Scavenging","volume":"60","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1994.4.129","article-title":"Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis","volume":"4","year":"1994","journal-title":"Thyroid"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1381612013397898","article-title":"The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling: a review","volume":"7","year":"2001","journal-title":"Current Pharmaceutical Design"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/eje.0.1360081","article-title":"Suppression of serum thyrotropin with thyroxine in patients with Graves\u2019 disease: effects on recurrence of hyperthyroidism and thyroid volume","volume":"136","year":"1997","journal-title":"European Journal of Endocrinology"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","year":"2015","journal-title":"Expert Opinion on Drug Metabolism and Toxicology"},{"key":"ref1981","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3565(25)09476-5","article-title":"The chemical nature of compounds which inhibit the function of the thyroid gland","volume":"78","year":"1943","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis. Thyroid storm","volume":"22","year":"1993","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-48-4-572","article-title":"Changes in thyroid-stimulating immunoglobulins during antithyroid therapy","volume":"48","year":"1979","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/qjmed\/92.8.455","article-title":"Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections","volume":"92","year":"1999","journal-title":"Quarterly Journal of Medicine"},{"key":"ref451","first-page":"505","article-title":"Comparative bioavailability of carbimazole and methimazole","volume":"21","year":"1983","journal-title":"International Journal of Clinical Pharmacology, Therapy and Toxicology"},{"key":"ref2031","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/thy.2016.0652","article-title":"Long-term antithyroid drug treatment: a systematic review and meta-analysis","volume":"27","year":"2017","journal-title":"Thyroid"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1038\/ncomms8633","article-title":"Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study","volume":"6","year":"2015","journal-title":"Nature Communications"},{"key":"ref2501","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.1.01993","article-title":"A systematic review of drug therapy for Graves\u2019 hyperthyroidism","volume":"153","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref1901","first-page":"1343","article-title":"American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume-title":"Thyroid","volume":"2016","year":"2016"},{"key":"ref441","first-page":"1004","article-title":"The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status","volume":"46","year":"2008","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"ref1551","first-page":"873","article-title":"Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline); report of 120 cases","volume":"1","year":"1953","journal-title":"Lancet"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem.74.4.1532179","article-title":"Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves\u2019 retroocular fibroblasts","volume":"74","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.2003.01850.x","article-title":"Peripheral parameters of oxidative stress in Graves\u2019 disease: the effects of methimazole and 131 iodine treatments","volume":"59","year":"2003","journal-title":"Clinical Endocrinology"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2010-1935","article-title":"A new small-molecule antagonist inhibits Graves\u2019 disease antibody activation of the TSH receptor","volume":"96","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1961","article-title":"Life-threatening thyrotoxicosis","volume-title":"Endocrine and Metabolic Medical Emergencies: A Clinician\u2019s Guide","year":"2018"},{"key":"ref2051","first-page":"Cd003420","article-title":"Antithyroid drug regimen for treating Graves\u2019 hyperthyroidism","volume":"1","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref611","first-page":"Cd003420","article-title":"Antithyroid drug regimen for treating Graves\u2019 hyperthyroidism","volume":"1","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","article-title":"Carbimazole embryopathy: an emerging phenotype","volume":"132a","year":"2005","journal-title":"American Journal of Medical Genetics: Part A"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.K05-121","article-title":"TSH receptor antibody measurements and prediction of remission in Graves\u2019 disease patients treated with minimum maintenance doses of antithyroid drugs","volume":"53","year":"2006","journal-title":"Endocrine Journal"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States","volume":"23","year":"2013","journal-title":"Thyroid"},{"key":"ref2161","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/thy.2014.0150","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"24","year":"2014","journal-title":"Thyroid"},{"key":"ref2531","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/thy.2014.0084","article-title":"Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg\/day and methimazole 30 mg\/day as initial therapy for Graves\u2019 disease patients with moderate to severe hyperthyroidism","volume":"25","year":"2015","journal-title":"Thyroid"},{"key":"ref851","year":"2018","journal-title":"Life-Threatening ThyrotoxicosisL"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4158\/EP.8.3.222","article-title":"Methimazole-induced hepatotoxicity","volume":"8","year":"2002","journal-title":"Endocrine Practice"},{"key":"ref2731","first-page":"w14243","article-title":"Rapid preoperative blockage of thyroid hormone production\/secretion in patients with Graves\u2019 disease","volume":"146","year":"2016","journal-title":"Swiss Medical Weekly"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jcem-5-10-424","article-title":"Thiouracil derivatives of greater activity for the treatment of hyperthyroidism","volume":"5","year":"1945","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2471","first-page":"475","article-title":"Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves\u2019 hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study","volume":"144","year":"2001","journal-title":"European Journal of Endocrinology"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The Thyroid Study Group","volume":"326","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"ref1911","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves\u2019 disease: an evidence-based approach to therapeutic controversies","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1881","first-page":"1004","article-title":"The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status","volume":"46","year":"2008","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","article-title":"2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).","volume":"63","year":"2016","journal-title":"Endocrine Journal"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1537-2995.1983.23283172851.x","article-title":"An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome","volume":"23","year":"1983","journal-title":"Transfusion"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(79)90692-0","article-title":"Accumulation of 2-[14C]propylthiouracil in human polymorphonuclear leukocytes","volume":"28","year":"1979","journal-title":"Biochemistry and Pharmacology"},{"key":"ref2801","first-page":"64","article-title":"Thyrotoxicosis and collagen-like disease in three sisters of American Indian extraction","volume":"76","year":"1970","journal-title":"Jurnalul Pediatrului"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/exer.1997.0353","article-title":"Superoxide radical production stimulates retroocular fibroblast proliferation in Graves\u2019 ophthalmopathy","volume":"65","year":"1997","journal-title":"Experimental Eye Research"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1530\/acta.0.0790248","article-title":"Binding of the 35-s of 35-s-propylthiouracil by follicular thyroglobulin in vivo and in vitro","volume":"79","year":"1975","journal-title":"Acta Endocrinology"},{"key":"ref2091","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-62-1-217","article-title":"Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests","volume":"62","year":"1986","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem.74.4.1532179","article-title":"Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves\u2019 retroocular fibroblasts","volume":"74","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/179\/5\/EJE-18-0678.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/179\/5\/EJE-18-0678.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T21:12:57Z","timestamp":1751836377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/179\/5\/R261\/6655402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":286,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1530\/eje-18-0678","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}